0000000000191085

AUTHOR

L Wang

showing 5 related works from this author

DNA Nanostructures in Cell Biology and Medicine

2017

Drug delivery endocytosis DNA aptamers Dip Pen NanolithographyDna nanostructuresDip-pen nanolithographyDrug deliveryNanotechnologyBiologyDNA AptamersEndocytosisCell biology
researchProduct

The global burden of chronic urticaria for the patient and society*

2020

Chronic urticaria (CU) affects about 1% of the world population of all ages, mostly young and middle-aged women. It usually lasts for several years (> 1 year in 25-75% of patients) and often takes > 1 year before effective management is implemented. It presents as chronic spontaneous urticaria (CSU), chronic inducible urticaria (CIndU) or both in the same person. More than 25% of cases are resistant to H1 -antihistamines, even at higher doses, and third- and fourth-line therapies (omalizumab and ciclosporin) control the disease only in two-thirds of H1 -antihistamine-resistant patients. Here we review the impact of CU on different aspects of patients' quality of life and the burden of this …

Pediatricsmedicine.medical_specialtyUrticariaOmalizumabDermatologyOmalizumabDisease030207 dermatology & venereal diseases03 medical and health sciencesIndirect costs0302 clinical medicineQuality of lifemedicineHumansChronic UrticariaDepression (differential diagnoses)business.industryUrticària -- TractamentDermatology Life Quality IndexMiddle AgedSalut públicaEuropeSexual dysfunctionQualitat de vidaChronic DiseasePresenteeismQuality of LifeIndicadors econòmicsFemalemedicine.symptombusinessmedicine.drugBritish Journal of Dermatology
researchProduct

Searching for New Physics in two-neutrino double beta decay with CUPID

2021

Abstract In the past few years, attention has been drawn to the fact that a precision analysis of two-neutrino double beta decay (2υββ) allows the study of interesting physics cases like the emission of Majoron bosons and possible Lorentz symmetry violation. These processes modify the summed-energy distribution of the two electrons emitted in 2υββ. CUPID is a next-generation experiment aiming to exploit 100Mo-enriched scintillating Li2MoO4 crystals, operating as cryogenic calorimeters. Given the relatively fast half-life of 100Mo 2υββ and the large exposure that can be reached by CUPID, we expect to measure with very high precision the 100Mo 2υββ spectrum shape, reaching great sensitivities…

CUPID Neutrinoless Double Beta Decay LNGS Particle Physics Neutrino Majorana NeutrinoHistoryLNGS[PHYS.NEXP]Physics [physics]/Nuclear Experiment [nucl-ex]hiukkasfysiikkaNeutrinoless Double Beta DecayEducationcrystalCUPIDNeutrino[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]double-beta decay: (2neutrino)Particle Physicsscintillation countersymmetry: violationbackgroundnew physics: search forMajorana Neutrinoneutriinotsensitivityviolation: LorentzMajoronComputer Science Applicationscalorimeter: cryogenicselectron: energy spectrumsymmetry: Lorentzydinfysiikka
researchProduct

Seeing Double:ASASSN-18bt Exhibits a Two-Component Rise in the Early-Time K2 Light Curve

2018

On 2018 Feb. 4.41, the All-Sky Automated Survey for SuperNovae (ASAS-SN) discovered ASASSN-18bt in the K2 Campaign 16 field. With a redshift of z=0.01098 and a peak apparent magnitude of B_{max}=14.31, ASASSN-18bt is the nearest and brightest SNe Ia yet observed by the Kepler spacecraft. Here we present the discovery of ASASSN-18bt, the K2 light curve, and pre-discovery data from ASAS-SN and the Asteroid Terrestrial-impact Last Alert System (ATLAS). The K2 early-time light curve has an unprecedented 30-minute cadence and photometric precision for an SN~Ia light curve, and it unambiguously shows a ~4 day nearly linear phase followed by a steeper rise. Thus, ASASSN-18bt joins a growing list o…

PhysicsHigh Energy Astrophysical Phenomena (astro-ph.HE)Field (physics)FOS: Physical sciencesAstronomy and AstrophysicsAstrophysicsRadiusindividual (ASASSN-18bt SN 2018oh) [supernovae]Light curve01 natural sciencesPower lawRedshiftSupernovaApparent magnitude13. Climate actionSpace and Planetary ScienceAsteroid0103 physical sciencesQD010306 general physicsAstrophysics - High Energy Astrophysical Phenomena010303 astronomy & astrophysicsQCQB
researchProduct

Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countrie…

2015

Summary Background Up-to-date evidence about levels and trends in disease and injury incidence, prevalence, and years lived with disability (YLDs) is an essential input into global, regional, and national health policies. In the Global Burden of Disease Study 2013 (GBD 2013), we estimated these quantities for acute and chronic diseases and injuries for 188 countries between 1990 and 2013. Methods Estimates were calculated for disease and injury incidence, prevalence, and YLDs using GBD 2010 methods with some important refinements. Results for incidence of acute disorders and prevalence of chronic disorders are new additions to the analysis. Key improvements include expansion to the cause an…

MaleGerontologyNutrition and DiseaseEpidemiologyyears lived with disability Global burden of disease acute and chronic diseases countriesPrevalenceDiseaseGlobal HealthMedical and Health SciencesConduct disorderOtitis-mediaCost of IllnessResidence CharacteristicsVoeding en ZiekteEpidemiologyPrevalence80 and overGlobal health2.2 Factors relating to the physical environment2.1 Biological and endogenous factorscountriesAetiologyChildAged 80 and overMedicine(all)education.field_of_studyATTENTION-DEFICIT/HYPERACTIVITY DISORDERIncidenceMortality rateIncidence (epidemiology)Pain ResearchNeglected DiseasesAlcohol dependenceGeneral MedicineMiddle AgedGlobal burden of diseaseGlobal Burden of Disease Study 2013 CollaboratorsMental HealthInfectious DiseasesAttention deficit/Hyperactivity disorderBurden of IllnessChild PreschoolAcute DiseaseFemaleLife Sciences & BiomedicineAdultmedicine.medical_specialtyAdolescentGBD 2013Populationacute and chronic diseasesYoung AdultMental-disordersAge DistributionMedicine General & InternalWeightsGeneral & Internal MedicinemedicineHumansLife ScienceDisabled PersonsSex DistributionPreschooleducationDeveloping CountriesVLAGAgedScience & Technologybusiness.industryDeveloped CountriesCutaneous LeishmaniasisInfant NewbornInfantHealth outcomesNewbornmedicine.diseaseComorbidityBrain Disordersyears lived with disabilityGood Health and Well BeingDisease injury incidence prevalence YLDs GBD 2010Chronic DiseaseWounds and Injuriesbusiness2.4 Surveillance and distributionIron-deficiencyDemography
researchProduct